Aquestive Therapeutics Stock Discussion

$Aquestive Therapeutics (AQST.US)$
Aquestive Therapeutics Announces Positive Topline PK Results from its Pediatric Study and Completes the NDA Submission for Anaphylm™ (epinephrine) Sublingual Film
Tuesday, 1st April at 7:00 am
Reports positive pharmacokinetic (PK) results from the recently completed pediatric study for Anaphylm™
Completes submission of its New Drug Application (NDA) for Anaphylm to the FDA; NDA acceptance expected in Q2 2025
WARREN, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- ...

$Aquestive Therapeutics (AQST.US)$ Aquestive Therapeutics Announced Topline Results From Its Pediatric Study For Anaphylm (Epinephrine) Sublingual Film In Patients Aged 7 To 17 And Weighing Over 30kgs With A Personal History Of Allergic Reactions, FDA Application Acceptance Expected In Q2 2025
Reports positive pharmacokinetic (PK) results from the recently completed pediatric study for Anaphylm.Completes submission of its New Drug Application (NDA) for Anaphylm to th...

$Capricor Therapeutics (CAPR.US)$ Safety: Deramiocel (CAP-1002) for Duchenne Muscular Dystrophy (DMD).
They have done over 700 infusions without any significant side effects. They will continue to do these at infusion centers just to be extra safe so treatment is available if there ever was a bad reaction.
Big things happening CAPR will be over 20+ soon
Apextradez where winning happens
XHLD alerted at .64c - think about that do you like HUGE profifs then...

Venrock Healthcare Capital Partners III 2,629,786 shares, 2.9%
$Aquestive Therapeutics (AQST.US)$
nfa

Bratton Douglas K. 10,023,384 shares, 11.1%
$Aquestive Therapeutics (AQST.US)$
nfa

$Humacyte (HUMA.US)$ $uniQure NV (QURE.US)$ $Aquestive Therapeutics (AQST.US)$ $IDEAYA Biosciences (IDYA.US)$ $Day One Biopharmaceuticals (DAWN.US)$
share your thoughts & ideas explain why 2025 will be amazing several break free and run
apextradez Wins so can you

$Aquestive Therapeutics (AQST.US)$ bring it on

$Aquestive Therapeutics (AQST.US)$
Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five
Thursday, 19th December at 8:00 am
WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery te...

$Aquestive Therapeutics (AQST.US)$ Reuters
1 min ago
Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms Nda Submission Guidance for Anaphylm™ (Epinephrine) Sublingual Film